FAYETTEVILLE, Ark., Aug. 19 -- The University of Arkansas issued the following news release:

A new study published in the Biophysical Journal has reported development of a stable, biologically active version of the human fibroblast growth factor. Human fibroblast growth factor, or FGF, has potent wound-healing and anti-diabetic properties that could prove useful in the development of new therapeutics.

The novel mechanism by which the researchers were able to enhance the structural stability and cell proliferative activity of FGF has been patent protected.

"FGFs are very important molecules," said Suresh Kumar Thallapuranam, corresponding author on the study and a University Professor of chemistry and biochemistry at the U of A. "In fact,...